# Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease

> **NCT02339142** · PHASE4 · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 100 (estimated)

## Conditions studied

- Graves Ophthalmopathy

## Interventions

- **RADIATION:** External beam radiotherapy
- **DRUG:** intravenous corticosteroids (methylprednisolone)

## Key facts

- **NCT ID:** NCT02339142
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339142, "Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02339142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*